Nevro - 10 Year Stock Price History | NVRO
Historical daily share price chart and data for Nevro since 2014 adjusted for splits and dividends. The latest closing stock price for Nevro as of December 24, 2024 is 3.97.
- The all-time high Nevro stock closing price was 184.34 on December 23, 2020.
- The Nevro 52-week high stock price is 22.15, which is 457.9% above the current share price.
- The Nevro 52-week low stock price is 3.52, which is 11.3% below the current share price.
- The average Nevro stock price for the last 52 weeks is 9.76.
| Nevro Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2024 | 9.7105 | 20.7600 | 20.7800 | 3.5900 | 3.9700 | -81.55% |
| 2023 | 25.7409 | 39.7200 | 41.1100 | 14.1800 | 21.5200 | -45.66% |
| 2022 | 53.6598 | 85.2700 | 92.0600 | 36.4300 | 39.6000 | -51.15% |
| 2021 | 137.2119 | 171.5400 | 182.1800 | 81.0700 | 81.0700 | -53.17% |
| 2020 | 133.7780 | 118.0100 | 184.3400 | 70.2300 | 173.1000 | 47.27% |
| 2019 | 71.3183 | 36.5500 | 117.5400 | 35.5200 | 117.5400 | 202.24% |
| 2018 | 67.6168 | 69.4600 | 92.5000 | 35.4300 | 38.8900 | -43.67% |
| 2017 | 84.0505 | 75.1700 | 99.1900 | 65.9400 | 69.0400 | -4.98% |
| 2016 | 75.8518 | 66.5000 | 104.9400 | 48.3400 | 72.6600 | 7.63% |
| 2015 | 49.1422 | 38.9500 | 68.3400 | 36.2600 | 67.5100 | 74.58% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.142B | $0.425B |
| Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. The company is known for developing and commercializing the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Additionally, the company's HF10 therapy provides long-lasting relief from chronic back and leg pain. Nevro's flagship Senza SCS system has been consistently driving the top line. Since its commercial launch in the United States, the system raked in significant revenues. These apart, Senza is commercially available in Europe since 2010 and in Australia since 2011. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $200.449B | 24.45 |
| Intuitive Surgical (ISRG) | United States | $186.791B | 97.66 |
| Edwards Lifesciences (EW) | United States | $44.123B | 28.02 |
| Alcon (ALC) | Switzerland | $41.807B | 27.97 |
| IQVIA Holdings (IQV) | United States | $35.805B | 19.73 |
| IDEXX Laboratories (IDXX) | United States | $33.758B | 39.76 |
| DexCom (DXCM) | United States | $31.263B | 47.08 |
| Waters (WAT) | United States | $21.860B | 32.32 |
| STERIS (STE) | Ireland | $20.481B | 23.58 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.736B | 0.00 |
| Hologic (HOLX) | United States | $16.260B | 17.56 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.386B | 13.74 |
| Sysmex ADR (SSMXY) | Japan | $11.751B | 0.00 |
| Globus Medical (GMED) | United States | $11.252B | 28.49 |
| Penumbra (PEN) | United States | $9.308B | 91.18 |
| Masimo (MASI) | United States | $9.076B | 43.92 |
| Glaukos (GKOS) | United States | $8.319B | 0.00 |
| Teleflex (TFX) | United States | $8.274B | 13.20 |
| Integer Holdings (ITGR) | United States | $4.484B | 25.41 |
| PROCEPT BioRobotics (PRCT) | United States | $4.236B | 0.00 |
| Inari Medical (NARI) | United States | $3.246B | 0.00 |
| Veracyte (VCYT) | United States | $3.169B | 95.09 |
| LivaNova (LIVN) | United Kingdom | $2.584B | 14.92 |
| Nihon Kohden (NHNKY) | Japan | $2.392B | 18.17 |
| Tandem Diabetes Care (TNDM) | United States | $2.358B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.084B | 18.74 |
| TransMedics (TMDX) | United States | $2.071B | 65.64 |
| Integra LifeSciences Holdings (IART) | United States | $1.682B | 8.79 |
| RxSight (RXST) | United States | $1.357B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.326B | 0.00 |
| Artivion (AORT) | United States | $1.194B | 79.11 |
| Pulse Biosciences (PLSE) | United States | $1.106B | 0.00 |
| OPKO Health (OPK) | United States | $1.051B | 0.00 |
| Paragon 28 (FNA) | United States | $0.840B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.739B | 12.56 |
| Mesa Laboratories (MLAB) | United States | $0.717B | 16.91 |
| IRadimed (IRMD) | United States | $0.693B | 37.43 |
| AxoGen (AXGN) | United States | $0.688B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.666B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.573B | 30.14 |
| SiBone (SIBN) | United States | $0.556B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.542B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.540B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.434B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.429B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.408B | 22.08 |
| AngioDynamics (ANGO) | United States | $0.361B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.352B | 0.00 |
| NeuroPace (NPCE) | United States | $0.344B | 0.00 |
| CVRx (CVRX) | United States | $0.294B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.217B | 0.00 |
| Inogen (INGN) | United States | $0.202B | 0.00 |
| Accuray (ARAY) | United States | $0.186B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.184B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.181B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.121B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.116B | 12.46 |
| Spectral Diagnostics (EDTXF) | Canada | $0.091B | 0.00 |
| LENSAR (LNSR) | United States | $0.089B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.089B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.081B | 0.00 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| 908 Devices (MASS) | United States | $0.072B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.071B | 0.00 |
| Hyperfine (HYPR) | United States | $0.065B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.064B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.061B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.044B | 0.00 |
| Neuronetics (STIM) | United States | $0.042B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.039B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| NexGel (NXGL) | United States | $0.032B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.029B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.024B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.023B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.012B | 0.00 | |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.009B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.007B | 0.00 |
| PAVmed (PAVM) | United States | $0.006B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |